Flow Cytometry in Oncology and Immunology Market to be dominated by Oncology Type through 2028
Rising expansion of flow
cytometry for research activities is expected to drive the growth of Global
Flow Cytometry in Oncology and Immunology market.
According to TechSci Research
report, “Flow Cytometry in Oncology and Immunology Market - Global Industry Size,
Share, Trends, Competition, Opportunity, and Forecast, 2018-2028,” the Global Flow Cytometry in
Oncology and Immunology Market is likely to register an impressive CAGR in the
forecast period, 2024-2028 on account of rising prevalence of cancer cases.
Flow cytometry (FCM) is
a multi-parameter analytical laboratory test for the characterization of single
cells and has been widely used in preclinical as well as in clinical cancer
immunotherapy studies. FCM is a technique of
measuring the number and characteristics of single cell that are flowing
through a detector system, using a fluorochrome-labeled monoclonal antibody.
However, stringent
regulatory scenario related to high cost of the products of the flow cytometry equipment,
false antibody responses and the lack of awareness slows down the market growth
in the coming years. Also, lack of skilled professionals to conduct sensitive
surgeries/therapies can further slowdown the market growth.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Flow Cytometry in Oncology and Immunology Market”
Global
Flow Cytometry in Oncology and Immunology Market can be segmented into type, technology, offering,
application, end user, region, and company. Based on type, the market can be segmented into immunology,
oncology. The segment oncology is expected to show an
impressive growth in the forecast period due to rising prevalence of cancer.
Based
on technology, the market can be
segmented into cell-based
flow cytometry, bead-based flow cytometry. The segment cell-based flow cytometry shows an impressive
growth in the future due to rapid advancement in therapies for single cells.
Based
on application, the market can be
segmented into translational
research and clinical research. The segment translational research is expected to show an
impressive growth in the forecast period due to recent scientific discoveries.
The
leading companies operating in the global flow cytometry in oncology and immunology
market are:
- Danaher Corporation
- Merck KGaA
- Miltenyi Biotec
- Neo-Genomics Laboratories, Inc.
- Thermo Fisher Scientific Inc
- Cell Signaling Technology, Inc
- Becton, Dickinson and Company
- Agilent Technologies, Inc.
- DiaSorin S.p.A (Luminex
Corporation)
- OPKO Health, Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“North America is expected to
dominate the global flow cytometry in oncology and immunology market during the
forecast period on account of rising prevalence of cancer cases, recent development,
and product launches. Additionally, high market penetration rate of
technologically advanced immune-oncology therapies is expected to increase the
demand for flow cytometry in oncology and immunology market in the coming
years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a
research based global management consulting firm.
“Flow
Cytometry in Oncology and Immunology Market - Global Industry Size, Share,
Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Type
(Immunology, Oncology), By Technology (Cell-Based Flow Cytometry, Bead-Based
Flow Cytometry), By Offering (Reagents, Instruments, and Consumables Software),
By Application (Translational Research, Clinical Research), By End User
(Hospitals, Diagnostic Laboratories, and Reference Laboratories, Pharmaceutical
and Biotechnology Companies, Academic Research Institutes, Contract Research
Organizations, and Others), By Region,” has evaluated the future growth potential
of Global Flow Cytometry in Oncology and Immunology Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Flow Cytometry in Oncology and
Immunology Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com